Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation - ADVANCE

Description:

Patients with type 2 diabetes were randomly assigned to undergo either standard glucose control or intensive glucose control with gliclazide and other agents to achieve a glycated hemoglobin (HbA1c) value of ≤6.5%.